A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®
摘要:
The structure-activity relationship of a series of styrylpyridine analogs of MK-0476 (montelukast, Singulair(R)) is described. This work has led to the identification of a number of potent and orally active cysLT(1), receptor (LTD4 receptor) antagonists including 2ab (1,-733,321) as an optimized candidate. (C) 1998 Elsevier Science Ltd. All rights reserved.
NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS
申请人:ELI LILLY AND COMPANY
公开号:EP1397364B1
公开(公告)日:2007-07-25
[EN] METHODS OF INHIBITING TGF BETA WITH SUBSTITUTED PYRAZOLES<br/>[FR] PROCEDES RELATIFS A L'INHIBITION DU TGF-BETA PAR LE BIAIS DE PYRAZOLES SUBSTITUES
申请人:LILLY CO ELI
公开号:WO2004026302A1
公开(公告)日:2004-04-01
Substituted pyrazoles are disclosed useful in the treatment of cancer and other disease states influenced by TGF beta by inhibiting TGF-β in a patient in need thereof.
A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®
The structure-activity relationship of a series of styrylpyridine analogs of MK-0476 (montelukast, Singulair(R)) is described. This work has led to the identification of a number of potent and orally active cysLT(1), receptor (LTD4 receptor) antagonists including 2ab (1,-733,321) as an optimized candidate. (C) 1998 Elsevier Science Ltd. All rights reserved.
Mechanism-based inactivation of catechol 2,3-dioxygenase by 3-[(methylthio)methyl]catechol